Basic Information
RNALocate ID: | RLID:11004346 |
RNA Symbol: | hsa-miR-1275 |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-1275 |
RNA ID: | miRBase:MIMAT0005929 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 20976003 |
Tissue/Cell Line: | Breast cancer cell line (MCF-7) |
Method: | Microarray |
Description: | Because of the suggested roles of extracellular miRNAs in signaling and diagnosis, we investigated whether the intracellular and extracellular miRNA composition are the same. To answer this question, we performed microRNA microarray analyses of MCF7 cellular (c) and extracellular (x) RNAs (Figure 2A), and found that about 66% of the released miRNAs are at an abundance that closely reflects the cellular miRNA abundance (Figures 2B and 2C). This finding is in agreement with a model wherein most, but not all miRNAs are released passively by mass action. Data are collected from Figure 2. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002786 | Mitochondrion | HeLa cells | 27396686 |
RLID:01002787 | Mitochondrion | HeLa cells | 27563705 |
RLID:01002788 | Mitochondrion | Cell line (HeLa) | 21695135 |
RLID:01002789 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01002790 | Nucleolus | HeLa cells | 23940654 |
RLID:01002837 | Cytosol | Cell line (HeLa) | 21695135 |
RLID:01002838 | Mitochondrion | Cell line (HeLa) | 21695135 |
RLID:11004347 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
RLID:11004348 | Microvesicle | Seminal plasma | 23539611 |
RLID-D:11000791 | Microvesicle | Colon cancer cell line (LIM1863)|Mesenchymal stem cells | |
RLID-D:11001721 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-1275 | Oral squamous cell carcinoma | MNDR-E-MI-08791 |
MNDR | hsa-miR-1275 | Estrogen-receptor positive breast cancer | MNDR-E-MI-08792 |
MNDR | hsa-miR-1275 | Estrogen-receptor negative breast cancer | MNDR-E-MI-08793 |
MNDR | hsa-miR-1275 | Progesterone-receptor positive breast cancer | MNDR-E-MI-08794 |
MNDR | hsa-miR-1275 | Progesterone-receptor negative breast cancer | MNDR-E-MI-08795 |
MNDR | hsa-miR-1275 | Her2-receptor positive breast cancer | MNDR-E-MI-08796 |
MNDR | hsa-miR-1275 | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-08797 |
MNDR | hsa-mir-1275 | Colorectal carcinoma | MNDR-E-MI-08798 |
MNDR | hsa-miR-1275 | B cell acute lymphoblastic leukemia | MNDR-E-MI-08799 |
MNDR | hsa-miR-1275 | Prostate cancer | MNDR-E-MI-08800 |
MNDR | hsa-miR-1275 | Alzheimer disease | MNDR-E-MI-08801 |
MNDR | hsa-miR-1275 | Intracranial aneurysm | MNDR-E-MI-08802 |
MNDR | hsa-miR-1275 | Polycystic ovary syndrome | MNDR-E-MI-08803 |
MNDR | hsa-miR-1275 | Head and neck cancer | MNDR-E-MI-08804 |
MNDR | hsa-miR-1275 | Lung cancer | MNDR-E-MI-08805 |
MNDR | hsa-miR-1275 | Parkinson disease | MNDR-E-MI-08806 |
MNDR | hsa-miR-1275 | Breast cancer | MNDR-E-MI-08807 |
MNDR | hsa-mir-1275 | Squamous carcinoma | MNDR-E-MI-08808 |
MNDR | hsa-miR-1275 | Pancreatic cancer | MNDR-E-MI-08809 |
MNDR | hsa-miR-1275 | Nephroblastoma | MNDR-E-MI-08810 |
MNDR | hsa-miR-1275 | Multiple sclerosis | MNDR-E-MI-08811 |
MNDR | hsa-miR-1275 | Multiple sclerosis relapsing-remitting | MNDR-E-MI-08812 |
MNDR | hsa-miR-1275 | Ovarian cancer | MNDR-E-MI-08813 |
MNDR | hsa-miR-1275 | Glioma | MNDR-E-MI-08814 |
MNDR | hsa-miR-1275 | Amyotrophic lateral sclerosis | MNDR-E-MI-08815 |
MNDR | hsa-miR-1275 | Liver cancer | MNDR-E-MI-08816 |
MNDR | hsa-mir-1275 | Non-small cell lung cancer | MNDR-E-MI-08817 |
MNDR | hsa-miR-1275 | Lung adenocarcinoma | MNDR-E-MI-08818 |
MNDR | hsa-miR-1275 | Thyroid carcinoma | MNDR-E-MI-08819 |
MNDR | hsa-miR-1275 | Pancreatic adenocarcinoma | MNDR-E-MI-08820 |
MNDR | hsa-miR-1275 | Intrahepatic cholangiocarcinoma | MNDR-E-MI-08821 |
MNDR | hsa-miR-1275 | Cholangiocarcinoma | MNDR-E-MI-08822 |
MNDR | hsa-miR-1275 | Adenoma | MNDR-E-MI-08823 |
MNDR | hsa-miR-1275 | Progressive supranuclear palsy | MNDR-E-MI-08824 |
MNDR | hsa-mir-1275 | Carcinoma hepatocellular | MNDR-E-MI-08825 |
MNDR | hsa-miR-1275 | Hepatocellular carcinoma | MNDR-E-MI-08826 |
MNDR | hsa-miR-1275 | Hodgkin lymphoma | MNDR-E-MI-08827 |
MNDR | hsa-miR-1275 | Acute myelocytic leukemia | MNDR-E-MI-08828 |
MNDR | hsa-mir-1275 | Colorectal cancer | MNDR-E-MI-08829 |
MNDR | hsa-mir-1275 | Nasopharyngeal carcinoma | MNDR-E-MI-08830 |
MNDR | hsa-miR-1275 | Nasopharynx carcinoma | MNDR-E-MI-08831 |
MNDR | hsa-miR-1275 | Nasopharyngeal cancer | MNDR-E-MI-08832 |
MNDR | hsa-miR-1275 | Pseudorabies | MNDR-E-MI-08833 |
MNDR | hsa-miR-1275 | Subarachnoid hemorrhage traumatic | MNDR-E-MI-08834 |
MNDR | hsa-miR-1275 | Stroke lacunar | MNDR-E-MI-08835 |
MNDR | hsa-miR-1275 | Breast cancer her3+ negative | MNDR-E-MI-08836 |
MNDR | hsa-mir-1275 | Multiple sclerosis susceptibility | MNDR-E-MI-08837 |
MNDR | hsa-mir-1275 | Stroke susceptibility | MNDR-E-MI-08838 |
MNDR | hsa-miR-1275 | Tubulovillous adenoma | MNDR-E-MI-08839 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | AK3 | Homo sapiens | RR00064570 |
TOP